Showing results (11-20 of 169) with videos related to
Sort By:
Pageof 17
Experimental Cell Research|January 1, 1985
Control of HL-60 myeloid differentiation. Evidence of uncoupled growth and differentiation control, S-phase specificity, and two-step regulationA YenThe American Journal of Managed Care|April 20, 2001
Impact of poorly controlled hypertension on healthcare resource utilization and costL C Paramore, M T Halpern, P Lapuerta, et al.Journal of General Internal Medicine|October 27, 2001
Productivity, quality, and patient satisfaction: comparison of part-time and full-time primary care physiciansD G Fairchild, K S McLoughlin, S Gharib, et al.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|March 1, 1992
Inducers of leukemic cell differentiation cause down-regulation of RB gene expressionA Yen, S ChandlerJournal of Cellular Physiology|June 1, 1995
RB phosphorylation in sodium butyrate-resistant HL-60 cells: cross-resistance to retinoic acid but not vitamin D3A Yen, S VarvayanisImmunology Letters|March 1, 1983
Serum-free media for a human lymphocyte cell line and for pwm-stimulated peripheral blood lymphocytes: requirements for insulin, transferrin and albuminA Yen, R DuigouIn Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association|September 1, 1992
RB tumor suppressor gene expression responds to DNA synthesis inhibitorsA Yen, S VarvayanisExperimental Cell Research|September 1, 1994
Late dephosphorylation of the RB protein in G2 during the process of induced cell differentiationA Yen, S VarvayanisIn Vitro Cellular & Developmental Biology. Animal|June 14, 2000
Retinoic acid increases amount of phosphorylated RAF; ectopic expression of cFMS reveals that retinoic acid-induced differentiation is more strongly dependent on ERK2 signaling than induced GO arrest isA Yen, S VarvayanisEuropean Journal of Cell Biology|April 1, 1996
Retinoic acid-induced RB (retinoblastoma) hypophosphorylation enhanced by CGP 52411 (4,5-dianilinophthalimide), an EGF family tyrosine kinase receptor inhibitorA Yen, S SoongPageof 17